Legend Biotech Corp (LEGN) — Cash Flow Reinvestment Rate
Legend Biotech Corp (LEGN) has a Cash Flow Reinvestment Rate of 0.87x as of September 2025, reinvesting $25.01 Million (capex $5.00 Million plus investments $-20.00 Million) from operating cash flow of $28.80 Million. See Legend Biotech Corp (LEGN) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Legend Biotech Corp Cash Flow Reinvestment Rate (2018–2018)
Historical reinvestment intensity for Legend Biotech Corp across 1 annual periods. For the full cash flow conversion analysis, see LEGN cash generation efficiency.
Annual Cash Flow Reinvestment Rate for Legend Biotech Corp (2018–2018)
Year-by-year capital reinvestment analysis for Legend Biotech Corp. See Legend Biotech Corp financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2018 | 0.40x | $123.28 Million | $307.68 Million | $21.02 Million | — |